Related Experiment Video
Updated: Jul 18, 2025

06:58
An Application for Pairing with Wearable Devices to Monitor Personal Health Status
Published on: February 3, 2022
2.8K
Selective Prevention of Depression in Workers Using a Smartphone App: Randomized Controlled Trial
Mark Deady1, Daniel A J Collins1, Isobel Lavender1
1Black Dog Institute, Faculty of Medicine and Health, University of New South Wales, Randwick, Australia.
Journal of Medical Internet Research
|August 24, 2023
Summary
A smartphone app showed promise in reducing depressive and anxiety symptoms for stressed workers. High engagement with the app led to significant depression prevention and improved well-being.
Area of Science:
- Mental Health
- Digital Health
- Occupational Health
Background:
- Depression is preventable, but universal interventions have limited success.
- Workplace stress is a significant risk factor for depression.
- Targeting interventions to at-risk individuals is crucial but challenging.
Purpose of the Study:
- To evaluate a smartphone-based intervention (Anchored) for preventing depression in stressed workers.
- To assess the intervention's impact on depressive symptoms, anxiety, stress, and work performance.
Main Methods:
- A randomized controlled trial involving 2084 employed adults with moderate stress.
- Intervention group received a 30-day app-based cognitive behavioral and mindfulness intervention (Anchored).
- Control group received a psychoeducation website; outcomes assessed at baseline and 1, 3, and 6 months.
Main Results:
- No significant difference in overall depression onset between groups (intention-to-treat).
- Anchored users showed greater reduction in depressive symptoms and anxiety, and improved work performance.
- Highly engaged users (≥2/3 completion) had significantly lower depression onset (1.1% vs. 9.0%) and improved secondary outcomes.
Conclusions:
- The smartphone intervention (Anchored) showed potential for symptom reduction and functional improvement, particularly with high user engagement.
- Selective prevention of case-level depression was not achieved in the overall intention-to-treat analysis.
- Future research should focus on enhancing user engagement with digital mental health interventions.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
272
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
272
Long-term Depression
31.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.0K
Depressive Disorders: MDD and Dysthymia
175
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
175
Depression: Overview
277
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
277

